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Abstract
Objective. To perform a meta-synthesis of the evidence for modifiable lifestyle risk factors for inflamma-
tory polyarthritis (IP) and RA.
Methods. We performed a MEDLINE literature search. Casecontrol and cohort studies and systematic
reviews published from 1948 through February 2011 and studying modifiable risk factors for RA were
retrieved. The main outcome measure was diagnosis of RA according to the standard criteria.
Results. Smoking contributes up to 25% of the population burden of RA. The risk is dose related,
stronger in males and especially strong for anti-citrullinated peptide antibody positive (ACPA
+) RA through
an interaction with the shared epitope. After smoking cessation, there is, however, a latency of up to 20
years to return to baseline risk. Other associations are less definitive; however, prospective studies suggest
that dietary antioxidants and breastfeeding may be protective and that high coffee consumption may
increase RA risk. An inverse association with alcohol intake (especially in smokers) and with education/
social class (especially seropositive RA) and an increased risk with obesity (seronegative RA) is also noted.
Conclusion. There is a need for further large-scale prospective studies with a consistent definition of RA
phenotype (undifferentiated IP through to ACPA
+/RF
+ disease). This will ultimately afford the opportunity to
evaluate preventative population strategies for RA akin to the well-established programmes for cardio-
vascular disease and cancer, targeting common risk factors.
Key words: rheumatoid arthritis, review, risk factors, epidemiology, lifestyle, environment, smoking, alcohol,
diet, social class.
Introduction
The aetiology of RA remains an area of intense interest. In
recent years, there have been major advances in our under-
standing of genetic risk, aided by the genome-wide asso-
ciation studies. There has also been renewed interest in
environmental triggers and their potential interactions with
these susceptibility genes [1, 2]. In the absence of a
diagnostic test for RA, the 1987 ACR criteria have until re-
cently been the gold standard for disease definition [3, 4].
However, RA is part of a continuum from undifferentiated
inflammatory polyarthritis (IP) to classical RA and evolution
of disease may take up to 5 years [5]. The RA phenotype
may be a final pathway of a number of different combin-
ations of risk factors and an emerging concept is that
anti-citrullinated peptide antibody positive (ACPA
+) disease
may be a more homogenous entity with distinct aetiological
factors [610]. Diet and lifestyle factors are of particular
interest as they are, at least in theory, modifiable. The aim
of this review is to summarize current knowledge of lifestyle
factors implicated in the aetiology of RA and consider how
these can contribute to disease prevention strategies.
Methods
We conducted a MEDLINE literature search in February
2011 with the MeSH search terms in Fig. 1. Search
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the literature. Abstracts of casecontrol studies, cohort
studies and systematic reviews were screened, and suit-
able full-text articles were retrieved. The main outcome
measure was a diagnosis of RA according to the ARA
1958 or revised ACR 1987 classification criteria or by ex-
pert opinion. Studies only published in abstract form were
excluded. Selection of articles for inclusion was done by a
single author (M.L.). No additional quality criteria, date or
language limits were imposed. Studies using hospitaliza-
tion or death due to RA or erosive RA as the primary out-
come were excluded as these relate to RA severity rather
than incidence. Relevant studies from reference lists of
retrieved articles were also included (Fig. 2). Results for
some of the major studies as presented by the authors
were extracted [odds ratio (OR), relative risk (RR), inci-
dence rate ratio (IRR) or hazard ratio (HR) with 95% CI
in parentheses].
Results
Smoking
Smoking is the best-studied preventable risk factor for
RA. Initial twin studies were suggestive of an elevated
risk [11]. In a meta-analysis of 11 casecontrol studies
[7, 1222] and 5 cohort studies [2327] smoking was con-
sistently found to be a risk factor especially in males and
for RF
+ RA [OR for RF
+ RA 3.91 (2.78, 5.50) for male and
1.29 (0.94, 1.77) for female current smokers] [28]. The
Nurses’ Health Study and the Nurses’ Health Study II
are two large US-based cohorts following a total of
238308 female nurses aged 2542 years since 1976 and
1989, respectively. Data from these cohorts suggest
a dose-dependent effect of pack-years of smoking, and
a threshold dose of 10 pack-years before an elevated risk
becomes evident [RR 1.35 (1.04, 1.74) for 1120 pack-
years compared with never-smokers]. The Iowa Women’s
Health Study (Iowa WHS), a prospective cohort of older,
post-menopausal Caucasian women, corroborated these
results [25]. It is estimated that smoking contrib-
utes 1825% of the population-attributable risk of RA
[24, 25]. There is a long latency, up to 20 years after
smoking cessation, to return to the risk level of a non-
smoker [24]. Klareskog and colleagues [29] proposed
that smoking may be a specific risk factor for only
ACPA
+ RA. In a national register-based casecontrol
study of incident RA [the Epidemiological Investigation
of RA (EIRA) in Sweden], it was noted that smoking inter-
acts with all alleles of the shared epitope (SE) to exponen-
tially increase the risk for RA [10]. Ever-smokers with two
copies of the SE had an RR of 21.0 (11.0, 40.2) for ACPA
+
RA as compared with non-smokers with no SE [10], a
finding supported by the Danish CaseControl Study of
RA (CACORA), the Nurses’ Health Study and a case-only
analysis from the Netherlands [7, 3032]. The population
attributable risk was much higher in this group, at 35% for
ACPA
+ RA and up to 55% in individuals with two copies of
the HLA-DRB1 SE [30, 33]. Importantly, there may be
ethnic and geographical variations in the association. A
North American case-only analysis did not support the
smokingSE interaction [34] and studies among Korean
and African American subjects have argued against its
FIG.1Search terms and strategy.
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Manjari Lahiri et al.specificity for ACPA
+ RA [35, 36]. It has also been sug-
gested that smoking specifically increases the risk in sub-
jects without the SE [37], that the risk may differ with
different SE alleles [38] and that there may be other mech-
anisms of pathogenesis [39]. Results from selected stu-
dies on the influence of smoking on risk of RA are
summarized in Table 1. The interaction of smoking with
other RA-associated genes such as protein tyrosine
phosphatase N22 (PTPN22), peptidyl arginine deiminase
type-4 (PADI-4) and cytotoxic T-lymphocyte antigen-4
(CTLA-4) is less clear, but data are rapidly emerging
[8, 40, 41]. For example, the Nurses’ Health Study
found an OR of 3.27 (1.74, 6.15) for RF
+ RA in smokers of
>10 pack-years who were carriers of the PTPN22 gene as
compared with non-carriers who smoked <10 pack-years
[40]. Passive smoking and smokeless tobacco have not
been found to be associated with RA risk [24, 42].
Diet
Omega-3 fatty acids
Omega-3 fatty acids have been shown in a number of
studies to ameliorate clinical symptoms of RA [4349]
and ecological studies in Japan and among Eskimos
have suggested that they may decrease the risk of RA
[5052]. Early retrospective casecontrol studies sup-
ported this [OR for the top vs the lowest quartile of olive
oil consumption 0.49 (0.30, 0.81) and for increase in con-
sumption by more than twice a week 0.38 (0.17, 0.85) in
two studies from Greece] [53, 54], especially for seroposi-
tive disease [OR for two or more vs less than one serving/
week of baked or broiled fish 0.57 (0.35, 0.93) for RA, 0.32
(0.14, 0.72) for RF
+ RA in an American study] [55]. The only
prospective study to examine these factors was the
Danish Diet, Cancer and Health (DCH) population-based
cohort of 57053 individuals. This study of incident RA
failed to confirm a protective effect of olive oil [IRR 1.00
(0.92, 1.08) per gram consumption]. Consumption of oily
fish did, however, show a trend towards a protective
effect [(IRR per 30g/day 0.51 (0.25, 1.03)] [56].
Antioxidants
A variety of health benefits have been attributed to con-
sumption of fruits and vegetables and are hypothesized to
be largely due to their antioxidant properties, which are
contributed by vitamins C and E, lycopene, caroteinoids,
flavonoids and possibly fructose-mediated urate produc-
tion [57]. Vitamin C and  -cryptoxanthin (a caroteinoid)
have been demonstrated to be protective in a systematic
review [58]. The Norfolk arm of the multicentre population-
based European Prospective Investigation of Cancer
(EPIC) study has followed about 25000 mainly
Caucasian participants aged >40 years since 1993 [59,
60]. Linkage with the Norfolk Arthritis Register
(NOAR)—a primary-care-based register of incident IP
with an overlapping catchment area [5] has given the op-
portunity for a prospective study of risk factors for IP. In
this study, there was an inverse association between con-
sumption of  -cryptoxanthin and vitamin C and RA risk
[OR 0.48 (0.24, 0.94) and 0.51 (0.25, 1.02) for the top vs
the bottom tertile of zeaxanthin and  -cryptoxanthin,
FIG.2Algorithm for selection of articles for review.
MEDLINE search
Five hundred and
thirty-six articles
Eighty-eight articles 
Ninety-eight articles cited in final review 
￿Ninety-two original articles 
￿Six systematic reviews/
meta-analyses 
Ten added from reference lists of 
retrieved articles 
Four hundred and forty-eight excluded 
￿OA/PsA/other diseases (101)  
￿Related to RA outcome/severity (184) 
￿Other risk factors (28) 
￿Serology/genetics (16) 
￿Review article/editorial/comment (114) 
￿Animal studies (6) 
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Manjari Lahiri et al.respectively, and 3.3 (1.4, 7.9) for the lowest vs the highest
tertile of vitamin C consumption] [61, 62]. Similar results
were obtained in the Iowa WHS [RR for highest vs lowest
tertile of  -cryptoxanthin intake 0.59 (0.39, 0.90)], which
also found a protective effect of dietary zinc supplements
[RR 0.39 (0.17, 0.88) for 15mg/day compared with non-
users] [63] and in a nested casecontrol study within a
Finnish cohort, which found an increased risk associated
with low pre-disease serum levels of selenium or a com-
posite antioxidant measure [64, 65]. However, the DCH
study and the Nurses’ Health Study found no benefit of
antioxidants, in spite of testing multiple parameters of
antioxidant content [56, 66] and a large randomized
double-blind placebo-controlled trial of vitamin E sup-
plements, the Women’s Health Study, which recruited
39876 female health professionals and followed them
for 10 years, showed no efficacy in the prevention of
RA, though there was a non-significant trend in RF
+
cases [RR for vitamin E (600IU every other day) vs pla-
cebo 0.64 (0.39, 1.06)] [67]. However, there is poor
generalizability between trials of a single vitamin and the
effects of whole fruit and vegetable consumption.
Observational studies have attempted to examine whole
foods. There was a protective effect for cooked vege-
tables [OR for highest vs lowest quartile 0.39 (0.20,
0.77)] in a Greek casecontrol study [54] and of fruit intake
in a nested casecontrol study from the EPIC-NOAR
[OR for lowest vs highest tertile of fruit consumption
2.1 (1.1, 4.2)]; however, other studies have shown no as-
sociation. For example, OR for the highest vs lowest tertile
of fruit consumption was 0.72 (0.46, 1.12) in the Iowa WHS
and IRR per 100g of fruit consumption 0.93 (0.79, 1.09) in
the DCH study [56, 63].
Red meat
There is a northsouth gradient in RA prevalence in
Europe and this may be associated with a protective
effect of the Mediterranean diet, or might be due to the
difference in per-capita red meat intake as suggested in
an ecological study [69]. Red meat consumption may be
inversely related to that of fruits, vegetables and oily fish. It
may also be associated with a higher overall fat and cal-
orie intake or lower fibre intake; and may indeed be a
surrogate marker for an unhealthier lifestyle. There have
been contradictory results from three prospective studies.
Whereas the EPIC-NOAR study found a positive associ-
ation with IP [OR 2.3 (1.1, 4.9) for the highest vs lowest
tertile of meat and meat products combined], the subse-
quent Danish DCH study and the Nurses’ Health Study did
not show any effect [56, 68, 70].
Alcohol
Moderate consumption of alcohol, especially red wine, is
proposed to protect against coronary heart disease, pos-
sibly because of its flavonoid content and antioxidant
properties [71]. Red wine is an inherent component
of the Mediterranean diet and may specifically act by
counteracting post-prandial oxidative stress [72]. Three
retrospective casecontrol studies have suggested that al-
cohol is associated with a decreased risk of RA [7, 12, 30,
73]. The risk reduction was confined to ACPA
+ RA in the
CACORA study [OR 0.6 (0.4, 0.9) for the highest quartile of
consumption vs low consumers (>0 to 50th centile)], but
for all RA in the Swedish EIRA study [OR 0.5 (0.4, 0.6) for
the same comparison] with the greatest risk reduction in
smokers carrying the SE [73]. Other studies have found
only a weak association [22]. A differential recall due
to reduced consumption of alcohol after diagnosis, espe-
cially in seropositive cases treated with MTX, may have
affected the results in these retrospective studies.
Prospective cohort studies do not thus far support a pro-
tective role of alcohol. The Iowa WHS, the EPIC-NOAR
study, the General Practice Research Database (GPRD)
(a population-based database of about 5 million patients
registered with selected general practitioners in the UK
since 1987) and a population-based male Finnish cohort
with 9777 participants did not find any association be-
tween alcohol consumption and the risk of RA, although
in the Iowa WHS alcohol did attenuate the increased risk
associated with smoking [68, 7476].
Caffeine
Coffee consumption has been studied as a risk determin-
ant of RA because of its association with smoking and
other potential dietary risk factors. A prospective study
of 19000 subjects in Finland found that drinking four or
more cups coffee per day was associated with RF
+ but
not RF
 RA [RR 2.20 (1.13, 4.27) for RF
+ RA as compared
with those who drank three or less cups] [77]. In the Iowa
WHS, the association was limited to decaffeinated coffee
consumption [RR 2.64 (1.46, 4.79) for RF
+ RA for four or
more cups/day vs none]. This study also found a trend
towards an inverse association with tea consumption
[RR for RF
+ RA 0.26 (0.06, 1.09) for consuming more
than 3 cups/day vs none] [78]. With an increased preva-
lence of atherosclerosis risk factors in the RA group, sub-
jects may adopt presumed healthier practices and
consumption of decaffeinated coffee may be a marker
of this effect [79]. Subsequent studies such as the
Nurses’ Health Study, the DCH and EPIC-NOAR studies
have not found a link between coffee, total caffeine or
decaffeinated coffee and RA [56, 68, 80]. These negative
studies may, of course, need to be examined separately
for ACPA
+ subsets; indeed, the CACORA study found a
strong association in 515 prevalent (<5 years) cases with
ACPA
+, but not ACPA
 RA [OR 2.18 (1.07, 4.42) for more
than 10 vs no cups of coffee/day for ACPA
+ RA and OR
1.23 (0.48, 3.16) for ACPA
 RA] [7] and especially in car-
riers of the SE [OR 53.3 (15.5, 183) for more than five
cups/day in SE homozygotes as compared with non-
drinkers with no SE; OR for non-drinker SE homozygotes
is 13.0 (3.3, 50.8)], an effect size similar in strength to
smoking in this study [30].
Vitamin D
Vitamin D deficiency is implicated in the pathogenesis of
several autoimmune conditions including multiple scler-
osis and Type 1 diabetes by its proposed role as an immu-
noregulatory hormone [81]. Its role in RA has been
investigated by measuring dietary intake in a number of
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WHS [RR for highest vs lowest tertile 0.67 (0.44, 1.00)]
have been negative [56, 68, 82, 83]. Dietary intake is, how-
ever, a poor estimate of vitamin D status as levels are
predominantly affected by latitude and sunlight exposure.
A small retrospective casecontrol study of 79 patients
from the Netherlands failed to show an association
between serum levels in blood donors and subsequent
development of RA [84].
Results from various studies on the dietary influences
on RA risk are summarized in Table 2. There is some
support for the protective role of antioxidant containing
foods, oily fish and alcohol and a possible increased risk
with coffee. The effect of vitamin D deficiency and red
meat remains unclear. Methodological differences may
explain some of the apparently contradictory findings.
For example, the 7-day diary method used in the EPIC
study correlates better with biomarkers of diet than
does the more widely used food frequency questionnaire
(FFQ). The presence of dietary measurement error inher-
ent in the FFQ attenuates the estimates of disease rela-
tive risk [8587]. There may also be residual confounding
from a healthy lifestyle effect, which is difficult to fully
account for in epidemiological studies. Randomized
trials tend to be reductionist in their nature, focusing
on a small number of candidate elements and cannot
examine the holistic effects of whole foods. As we have
seen, however, there is also evidence that some risk fac-
tors have significant associations only with specific ACPA
subsets.
Obesity
Obesity increases the amount of available oestrogen
through increased conversion of androstenedione to oes-
trone and decreased sex hormone binding globulin, espe-
cially in post-menopausal women [88]. Leptin, an
adipocyte-secreted hormone, has an increasingly recog-
nized role in regulating immune responses [89]. Elevated
levels of circulating leptin tend to drive immune responses
to a Th1 phenotype and increase production of pro-
inflammatory cytokines such as TNF-a and IL-1. This
may contribute to a common pathway leading towards
both RA and cardiovascular disease (CVD). Obesity was
associated with RA risk in three population based case
control studies [OR for BMI 530 vs <25=3.74 (1.14,
12.27) in the NOAR study, for the highest vs lowest quar-
tile of BMI 1.4 (1.0, 2.0) in an American casecontrol study
and for BMI 530 vs 18.5 to <25=3.45 (1.73, 6.87) for
ACPA
 RA in the CACORA study] [7, 20, 22]. Others,
including prospective studies, have found no association
of obesity with RA risk [21, 74, 76, 90]. The apparent
contradiction may be explained by the findings in the pro-
spective EPIC-NOAR study, where obesity was a risk
factor only when measured in proximity to the onset of
IP [OR 4.79 (1.17, 19.6) for IP onset 418 months of ques-
tionnaire], and not in the remote past [91]. Only two stu-
dies have assessed the effect of physical activity and with
conflicting results [7, 74].
Statins
The proposed anti-inflammatory effects of statins may
play a role in reducing RA risk [9294]. A nested
casecontrol study from the GPRD suggested that sta-
tins may reduce the risk of RA in patients with hyperlipid-
aemia [OR 0.59 (0.37, 0.96) for statin users compared
with untreated patients with hyperlipidaemia and OR
0.88 (0.55, 1.40) compared with non-hyperlipidaemic
controls] [92]. Subsequent studies in the same popula-
tion showed no association [76, 93]. A cohort study of
211627 individuals followed for >10 years with 2578 inci-
dent cases of RA from a health maintenance organization
in Israel found that high adherence to statins lowered the
risk of RA [HR 0.58 (0.52, 0.65) for those with 580% vs
<20% adherence] [94], but while they controlled for a
healthy user effect, they did not account for smoking as
a confounder.
Social class
Social class (SC) or education may be a marker for un-
measured lifestyle variables and is associated with a
poorer outcome in established RA [95], so it is attractive
to postulate that it may influence RA risk. The NOAR study
found no association between SC (defined by occupation
and areal housing indices of deprivation) and incident RA,
nor did a population-based study of 361 prevalent cases
in Norway [21, 96]. In contrast, a Swedish study found an
inverse association between higher education and inci-
dent RA, especially RF
+ disease [OR 0.3 (0.2, 0.7) for
men with schooling beyond compulsory education] [17].
This was supported by the EIRA study where subjects
without a university degree had an increased risk com-
pared with degree holders [OR for RF
+ RA 1.7 (1.2, 2.2)].
The association with occupational class was less clear
[OR for RF
+ RA for lower vs higher class 1.5 (1.0, 2.1)]
[97]. A similar inverse association with education was
found in the CACORA study [98]. Methodological differ-
ences may explain some of these conflicting results, es-
pecially variation of definition and ascertainment of SC
based on occupational class, educational attainment or
area-level deprivation indices.
Psychosocial factors
Work stress defined by low decision latitude, was asso-
ciated with an increased risk for RA in the EIRA study [OR
1.6 (1.2, 2.2) vs workers with high decision latitude] as was
shift work in a prospective Finnish study of 70000 mainly
female government employees [OR 1.36 (1.02, 1.82)] [99].
The NOAR investigators have suggested that reduced
adaptation scores, implying a reduced ability to cope
with stress may be an important factor [100].
Hormonal factors
RA is three times more common in women than in men,
and so it is intuitive that hormonal factors may play a role
in aetiology. Modifiable lifestyle factors involving hormonal
manipulation include the use of oral contraceptives (OCs)
and HRT, parity and breastfeeding.
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Modifiable risk factors for RAOCs
A possible inverse association between OC use and the
risk of RA has been the subject of debate since the 1970s
[23, 101113] and remains unresolved [114117]. More
recent large prospective cohorts such as the Nurses’
Health Study, the Malmo ¨ Study (a prospective cohort of
18326 women in Sweden with 136 cases of incident RA),
the GPRD and the Iowa WHS have examined ever-use of
OC and showed no association with RA risk [76, 118122];
although other studies have suggested a dose-dependent
risk reduction [123, 124]. Few population-based studies of
incident RA have included enough current users of OC.
The NOAR study found a protective effect limited to cur-
rent use [OR for current vs never-users 0.22 (0.06, 0.85),
OR for ever vs never-users 0.88 (0.47, 1.64)] [125]. This
was not replicated in the CACORA study [OR 1.0 (0.57,
1.76) for current vs never use] or the GPRD [7, 76].
Interestingly, the CACORA study found an increased risk
of ACPA
+ RA among ever-users of OC [OR 1.65 (1.06,
2.57) vs never users], with additive risk in SE carriers
[OR 2.27 (0.85, 6.04) for ever-users with no SE, OR 32.3
(9.93, 105) for non-users with SE homozygosity and OR
44.6 (15.2, 131) for SE homozygous ever-users; all com-
pared with non-users with no SE] [7, 30].
HRT
Though HRT involves supplementation of exogenous hor-
mones similar to OC, the dose of oestrogen is much
reduced, and the target population is of a different age
and menopausal status. Results have been consistently
negative for any influence of HRT on RA risk [119, 121,
123, 125127].
Pregnancy
Pregnancy classically results in amelioration of symptoms
of established RA, which then often flare post-partum.
Nulliparity could therefore be a risk factor for RA, either
through increased time at-risk or through a true immuno-
logical mechanism [109, 128]. Recent studies have failed
to show an association of pregnancy or parity with risk of
RA [90, 103, 120122, 125, 129, 130] and the association
with age at first or last pregnancy is inconsistent (Table 3)
[121, 128, 129, 131]. Pregnancy may, however, be a
time-varying risk factor [132]. The GPRD showed a
decreased risk of RA in the year following pregnancy
[76] and a recent casecontrol study demonstrated a de-
crease in risk most pronounced at 15 years after the last
child birth, which reduced with time [RR 0.29, P<0.001
within 15 years of last child birth; RR 0.51, P<0.001
within 515 years of last child birth and RR 0.76,
P=0.18 for >15 years since last child birth, all relative to
nulliparous women] [131].
Breastfeeding
Despite many health benefits, early evidence suggested
that RA risk was increased by breastfeeding, especially
after the first pregnancy, possibly due to a surge in the
pro-inflammatory hormone prolactin [133]. Another small
study found an increased risk associated with the duration
of breastfeeding especially in carriers of the PTPN22 allele
[OR 5.7 (1.25, 26.52) for breastfeeding 511 months and
no T-variant, OR 3.6 (0.44, 28.89) for no breastfeeding
and T-variant
+ and OR 14.0 (2.83, 69.24) for breastfeed-
ing 511 months and T variant
+] [124]. Prospective studies
have, however, found a dose-dependent inverse asso-
ciation with duration of breastfeeding and RA risk
[120122, 125]. These results may not, however, be ab-
solutely contradictory. The first episode of breastfeeding
may produce a prolactin surge and unmask latent RA in a
susceptible individual. If this first episode is survived from
an RA perspective, then the individual may breastfeed
longer and in subsequent pregnancies. Thus, the protec-
tion afforded by longer duration of breastfeeding may in
part be an example of depletion of susceptibles. Results
from selected studies on modifiable hormonal influences
and RA risk are summarized in Table 3.
Conclusions
It is therefore clear that lifestyle can influence the risk of
RA. We have, however, identified variability in many epi-
demiological factors, some of which can be explained by
study design (casecontrol vs prospective cohort studies),
definition of exposure, definition of outcome, serological
subsets and time-varying risk. Smoking is the most con-
sistent association, in both casecontrol and prospective
studies, and contributes up to 25% of the population
burden of RA. The risk is dose related, stronger in males
and especially strong in SE carriers for ACPA
+ RA.
Unfortunately, there is a latency of up to 20 years after
smoking cessation to return to baseline risk. From a public
health perspective, this is yet another reason to advise
young adults not to start smoking. Prospective studies
also support a protective role of antioxidants and breast-
feeding and an increased risk with coffee intake. There are
also at least three casecontrol studies suggesting an in-
verse association with alcohol intake and higher educa-
tion/SC and an increased risk with obesity. Obesity and
pregnancy may exert an effect in proximity to disease
onset, which reduces with time. Smoking, alcohol,
coffee and SC are all more consistently associated with
seropositive (RF
+ or ACPA
+) disease, whereas obesity and
breastfeeding may be particularly relevant in seronegative
disease. Further characterizing geneenvironment inter-
actions in the development of RA within this paradigm
will be a key priority and combining genetic and environ-
mental data in the same cohorts will be crucial to advan-
cing our understanding of the disease. Some of the
factors identified already form part of the healthy lifestyle
advice given for CVD and cancer prevention, and preven-
tion of RA may be a bystander motivating factor in
high-risk individuals such as those with first-degree rela-
tives with RA. Formalizing this into a focused prevention
programme is more challenging but may be a highly
cost-effective public health initiative.
Future perspectives
Many of the remaining questions regarding environmental
risk of RA will almost certainly require pooling results from
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Modifiable risk factors for RAlarge prospective cohorts and include common definitions
of exposures, disease phenotype and serological sub-
types. However, we are close to being able to combine
risk factors to develop a Framingham-style risk prediction
model for RA. It remains to be seen whether we will need
completely separate risk models for ACPA
+ and ACPA

disease. Clearly, there are several common risk factors be-
tween RA and CVD and pathways contributing to early
low-grade inflammation deserve further study. It also af-
fords the opportunity to evaluate the potential to draw
together preventative health messages for RA with those
for CVD and cancer for which such programmes are now
well established.
Rheumatology key messages
. Lifestyle risk factors for RA are potentially
modifiable.
. Smoking remains the most consistent environ-
mental risk factor for RA across studies.
. We are at the threshold of being able to risk-stratify
populations for RA prevention.
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